KAROLINA FAYSMAN: Open Payments
NPI 1336320407 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258,328 in 342 payments from 19 companies in 2025. Trend: 2023 $216,798 · 2024 $196,364 · 2025 $258,328
Speaker / faculty: $202,983Travel & lodging: $42,222Food & beverage: $9,543Consulting: $3,580
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 80 | $70,455 |
| SOBI, INC | 72 | $62,832 |
| Incyte Corporation | 72 | $56,478 |
| Syndax Pharmaceuticals, Inc. | 31 | $25,087 |
| GlaxoSmithKline, LLC. | 21 | $11,422 |
| PFIZER INC. | 15 | $9,514 |
| Genmab U.S., Inc. | 10 | $7,364 |
| ABBVIE INC. | 8 | $7,122 |
| BeOne Medicines USA, Inc. | 8 | $4,526 |
| BeiGene USA, Inc. | 2 | $1,620 |
Products named: RYBREVANT, Vonjo, Niktimvo, Monjuvi, REVUFORJ, EPKINLY, ELREXFIO, OJJAARA.
Industry payments across CA — which companies pay providers there.
